Convatec: FDA 510(k) clearances across all its applicant names
FDA lists 149 510(k) clearances, 0 PMA and 0 De Novo decisions across the 11 applicant names Caduvo groups under Convatec, first 1982, latest 2026. Median 510(k) review time across these names: 86 days. Since 2017 the median was 147 days, against 188 days for all cleared 510(k)s in the same product codes. Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 5 | 89 |
| 2013 | 2 | 147 |
| 2014 | 1 | 109 |
| 2015 | 1 | 160 |
| 2016 | 3 | 130 |
| 2017 | 3 | 141 |
| 2018 | 4 | 166 |
| 2019 | 2 | 88 |
| 2020 | 0 | — |
| 2021 | 1 | 142 |
| 2022 | 2 | 216 |
| 2023 | 1 | 266 |
| 2024 | 2 | 88 |
| 2025 | 3 | 116 |
| 2026 | 3 | 198 |
The 11 FDA applicant names in this group
| Applicant name | 510(k) clearances | PMA | De Novo | Years |
|---|---|---|---|---|
| Convatec, A Division of E.R. Squibb & Sons | 81 | 0 | 0 | 1982–2002 |
| Convatec | 15 | 0 | 0 | 2008–2026 |
| Convatec Limited | 14 | 0 | 0 | 1997–2026 |
| Unomedical A/S | 13 | 0 | 0 | 2003–2021 |
| Convatec, A Bristol-Myers Squibb Co. | 10 | 0 | 0 | 1994–2004 |
| Unomedical Sdn Bhd | 9 | 0 | 0 | 1995–1998 |
| Convatec, A Division of E.R. Squibb & Sons, LLC | 3 | 0 | 0 | 2007–2009 |
| Convatec Limited, Gdc Building | 1 | 0 | 0 | 2026–2026 |
| Convatec Triad Life Sciences, LLC | 1 | 0 | 0 | 2024–2024 |
| Unomedical A/S Infusion Devices | 1 | 0 | 0 | 2012–2012 |
| Unomedical Devices S.A DE C.V. | 1 | 0 | 0 | 2012–2012 |
Review time against the same product codes
Since 2017, 510(k)s cleared under these names took a median 147 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 188 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| FRO | Dressing, Wound, Drug | 26 | 26 |
| KMF | Bandage, Liquid | 15 | 15 |
| FPA | Set, Administration, Intravascular | 14 | 14 |
| EXB | Collector, Ostomy | 9 | 9 |
| BTR | Tube, Tracheal (W/Wo Connector) | 7 | 7 |
| EZD | Catheter, Straight | 6 | 6 |
| KGX | Tape And Bandage, Adhesive | 6 | 6 |
| KNT | Tubes, Gastrointestinal (And Accessories) | 6 | 6 |
| KNX | Collector, Urine, (And Accessories) For Indwelling Catheter | 5 | 5 |
| EXJ | Device, Incontinence, Urosheath Type, Sterile | 4 | 4 |
Plus 24 more product codes.
Review panels
- General and Plastic Surgery (67)
- Gastroenterology and Urology (54)
- General Hospital (20)
- Anesthesiology (7)
- Cardiovascular (1)
Most recent Convatec 510(k) clearances
| 510(k) | Device | Applicant name | Product code | Decision date | Review days |
|---|---|---|---|---|---|
| K260737 | Cure Aqua Ready to Use Hydrophilic Intermittent Catheter Female (CH06 - CH16); Cure Aqua Ready to Use Hydrophilic Intermittent Catheter Male Straight (CH06 - CH18); Cure Aqua Ready to Use Hydrophilic Intermittent Catheter Male Coude (CH10 - CH18). | Convatec | EZD | 2026-08-05 | 152 |
| K253263 | ConvaVAC Negative Pressure Wound Therapy System | Convatec Limited, Gdc Building | OMP | 2026-06-24 | 268 |
| K252943 | GentleCath Air for Men; GentleCath Glide Intermittent Catheter; GentleCath Air for Women | Convatec Limited | EZD | 2026-04-01 | 198 |
| K250699 | Cure Twist Female 8 Catheter (T8); Cure Twist Female 10 Catheter (T10); Cure Twist Female 12 Catheter (T12); Cure Twist Female 14 Catheter (T14); Cure Twist Female 16 Catheter (T16); Cure Twist Female 8 Catheter Kit with supplies (T8K); Cure Twist Female 10 Catheter Kit with supplies (T10K); Cure Twist Female 12 Catheter Kit with supplies (T12K); Cure Twist Female 14 Catheter Kit with supplies (T14K); Cure Twist Female 16 Catheter Kit with supplies (T16K) | Convatec | EZD | 2025-07-01 | 116 |
| K250891 | Cure Catheter Insertion Kit (K1); Cure Catheter Insertion Kit (K2); Cure Catheter Insertion Kit (K2-90); Cure Catheter Insertion Kit (K3); Cure Hydrophilic Catheter Kit (HM12UK); Cure Hydrophilic Catheter Kit (HM14UK); Cure Hydrophilic Catheter Kit (HM16UK); Cure Pocket Catheter Kit (M14UK); Cure Catheter Closed System Kit (CS8); Cure Catheter Closed System Kit (CS10); Cure Catheter Closed System Kit (CS12); Cure Catheter Closed System Kit (CS14); Cure Catheter Closed System Kit (CS14C | Convatec Limited | FCM | 2025-06-06 | 73 |
| K243228 | Flexi-Seal AIR (with ENFit Connector) | Convatec | KNT | 2025-03-28 | 171 |
| K241866 | InnovaMatrix®FD | Convatec Triad Life Sciences, LLC | KGN | 2024-07-26 | 29 |
| K232665 | GentleCath Air for Women (CH10); GentleCath Air for Women (CH12); GentleCath Air for Women (CH14) | Convatec | EZD | 2024-01-25 | 147 |
| K230400 | Cure Catheter Closed System; Cure Dextra Closed System | Convatec | EZD | 2023-11-08 | 266 |
| K221593 | Cure Ultra Male, Cure Ultra Female, Cure Ultra Plus | Convatec | EZD | 2022-11-17 | 168 |
139 earlier clearances. See the full list in Caduvo.
Recalls
78 product recalls in 41 recall events under these names; 22 initiated in the last five years.
19 product recalls in 6 recall events filed under other recalling-firm names cite a 510(k) or PMA held under these applicant names; 0 initiated in the last five years. Most often: Asante Solutions, Inc. (7), Unomedical As (6), Medtronic Inc. (4).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to the applicant names above by name only, so recalls filed under other names are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
ClinicalTrials.gov lists 41 device studies (8 active or recruiting) with an industry lead sponsor under the 1 sponsor name below. Most recent:
- NCT07438951: Efficacy and Safety of a Nitric Oxide Generating Dressing for Diabetic Foot Ulcers (ONWARD) (ConvaTec Inc.; Recruiting, started 2026-09-01)
- NCT07342049: ConvaVAC™ Ag+ Negative Pressure Wound Therapy System in Chronic Wounds (ConvaTec Inc.; Recruiting, started 2026-01-12)
- NCT07209358: EDX110 Randomized Control Trial for Treatment of DFUs (ConvaTec Inc.; Active not recruiting, started 2025-10-30)
- NCT06616844: IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers (ConvaTec Inc.; Active not recruiting, started 2025-02-12)
- NCT06640985: EDX110 - Efficacy and Safety in the Management of Hard-to-heal Wounds (ConvaTec Inc.; Active not recruiting, started 2024-12-04)
| Lead sponsor name on ClinicalTrials.gov | Device studies |
|---|---|
| ConvaTec Inc. | 41 |
Sponsor names are matched to the applicant names above by name, with punctuation and legal suffixes removed, plus sponsor names reviewed for this group. Studies listed under other sponsor names are not counted.
How this group is built
Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
ConvaTec was a Bristol-Myers Squibb division until 2008; its E.R. Squibb-era filings are included. Unomedical acquired 2008.
Sources
Frequently asked questions
How many FDA 510(k) clearances are listed across Convatec's applicant names?
FDA lists 149 510(k) clearances, 0 PMA and 0 De Novo decisions across the 11 applicant names Caduvo groups under Convatec, first 1982, latest 2026. FDA records each applicant name separately; Caduvo adds up the names listed on this page.
Which FDA applicant names does Convatec file under?
The names with the most 510(k) clearances in this group are Convatec, A Division of E.R. Squibb & Sons (81); Convatec (15); Convatec Limited (14); Unomedical A/S (13); Convatec, A Bristol-Myers Squibb Co. (10). The full list of 11 names is on this page.
How long does FDA take to clear Convatec 510(k)s?
The median time from FDA receipt to decision across 510(k)s cleared under these names is 86 days. Since 2017 the median was 147 days, against 188 days for all cleared 510(k)s in the same product codes.
Does the Convatec count include acquired companies?
Yes. A group includes filings an acquired business made under its own name, including before the acquisition. Businesses that were sold are left out, and names whose ownership is unclear are not included. FDA does not group applicants; the sources for each grouping are listed on this page.
How many device clinical trials does Convatec sponsor?
ClinicalTrials.gov lists 41 device studies (8 active or recruiting) with an industry lead sponsor under 1 sponsor name Caduvo groups under Convatec. ClinicalTrials.gov names the sponsor on each study; Caduvo adds up the names listed on this page.
Next steps
- See all 149 Convatec clearances with predicates and recalls
- Run predicate analysis for product code FRO, Convatec's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this grouping or data. Data and corrections policy.
All parent companies · FDA device companies by applicant name · FDA product code lookup